Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis.

about

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis.

Item

http://www.wikidata.org/entity/Q46246635

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Impact of inappropriate antifu ...... ity, a retrospective analysis.

@en

Impact of inappropriate antifu ...... ity, a retrospective analysis.

@nl

type

Item

label

Impact of inappropriate antifu ...... ity, a retrospective analysis.

@en

Impact of inappropriate antifu ...... ity, a retrospective analysis.

@nl

prefLabel

Impact of inappropriate antifu ...... ity, a retrospective analysis.

@en

Impact of inappropriate antifu ...... ity, a retrospective analysis.

@nl

P1476

Impact of inappropriate antifu ...... ity, a retrospective analysis.

@en

P2093

Andrea Rangel-Cordero

http://www.w3.org/2001/XMLSchema#string

Areli Martinez-Gamboa

http://www.w3.org/2001/XMLSchema#string

Consuelo Velázquez-Acosta

http://www.w3.org/2001/XMLSchema#string

José Sifuentes-Osornio

http://www.w3.org/2001/XMLSchema#string

Luis Ostrosky-Zeichner

http://www.w3.org/2001/XMLSchema#string

María Fernanda González-Lara

http://www.w3.org/2001/XMLSchema#string

Patricia Cornejo-Juárez

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

Echinocandin resistance: an emerging clinical problem?

Epidemiology of invasive candidiasis: a persistent public health problem

Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole.

Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center

Epidemiology of candidemia in Latin America: a laboratory-based survey.

P2888

s12879-017-2846-2

P304

753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-017-2846-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alfredo Ponce-de-Leon

Miriam Bobadilla-Del Valle

Pedro Torres-Gonzalez

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099703403

http://www.w3.org/2001/XMLSchema#string

P698

29212442

http://www.w3.org/2001/XMLSchema#string

P932

5719515

http://www.w3.org/2001/XMLSchema#string